AI assistant
Sending…
C4 Therapeutics, Inc. — Director's Dealing 2020
Oct 7, 2020
33861_dirs_2020-10-06_3bea734b-4b10-496b-9967-917c8178ae78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: C4 Therapeutics, Inc. (CCCC)
CIK: 0001662579
Period of Report: 2020-10-06
Reporting Person: MCKEE WILLIAM (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-10-06 | Common Stock | P | 5263 | $19.00 | Acquired | 5263 | Direct |
More from C4 Therapeutics, Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 9
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 18